Varian Medical Systems Inc. (VAR)

134.85
0.05 0.04
NYSE : Health Technology
Prev Close 134.90
Open 135.17
Day Low/High 133.83 / 135.57
52 Wk Low/High 101.42 / 142.50
Volume 544.98K
Avg Volume 538.10K
Exchange NYSE
Shares Outstanding 90.95M
Market Cap 12.30B
EPS 1.60
P/E Ratio 32.67
Div & Yield N.A. (N.A)

Latest News

Varian Provides TrueBeam System For IAEA Dosimetry Laboratory In Austria

Varian Provides TrueBeam System For IAEA Dosimetry Laboratory In Austria

PALO ALTO, Calif., July 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around the world deliver more precise radiotherapy doses.

Varian To Expand Interventional Oncology Portfolio With Purchase Of Embolic Bead Asset

Varian To Expand Interventional Oncology Portfolio With Purchase Of Embolic Bead Asset

Company to acquire assets from Boston Scientific to expand embolic bead offering

Varian Announces Third Quarter Fiscal Year 2019 Earnings Release Date

Varian Announces Third Quarter Fiscal Year 2019 Earnings Release Date

PALO ALTO, Calif., June 26, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its third quarter fiscal year 2019 earnings release date.

Varian To Provide Mobile Technology To Cancer Patients Across Tennessee

Varian To Provide Mobile Technology To Cancer Patients Across Tennessee

Collaboration with Tennessee Oncology Aims to Improve Access to Care Across Rural Patient Populations

Varian Completes Acquisition Of Cancer Treatment Services International

Varian Completes Acquisition Of Cancer Treatment Services International

PALO ALTO, Calif., June 17, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI).

Varian To Deliver Six Technical Presentations At ICCR

Varian To Deliver Six Technical Presentations At ICCR

PALO ALTO, Calif., June 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI),  federated data sources and clinical decision support at the 19 th International Conference on...

Proton Clinical Research Center Of The Shandong Cancer Hospital First APAC Member Of FlashForward Consortium

Proton Clinical Research Center Of The Shandong Cancer Hospital First APAC Member Of FlashForward Consortium

PALO ALTO, Calif., June 12, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pacific to join the FlashForward ™ Consortium.

Varian Medical Systems Presents Latest Innovations In Radiotherapy At DEGRO 25

Varian Medical Systems Presents Latest Innovations In Radiotherapy At DEGRO 25

MÜNSTER, Germany, June 12, 2019 /PRNewswire/ -- Varian (NYSE: VAR) will showcase and discuss its latest innovations in radiotherapy at the DEGRO 25 (German Society for Radio Oncology) meeting in Münster, Germany, June 13-16.

Varian To Demonstrate New Bravos Afterloader System At ABS 2019

Varian To Demonstrate New Bravos Afterloader System At ABS 2019

PALO ALTO, Calif., June 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced it will be showcasing its Bravos ™ afterloader system for High Dose Rate (HDR) brachytherapy treatments and other advanced brachytherapy solutions at the 2019 American...

Varian Expands Cancer Care Solutions Portfolio With Interventional Oncology Acquisitions

Varian Expands Cancer Care Solutions Portfolio With Interventional Oncology Acquisitions

Company acquires Endocare and Alicon to add cryoablation and microwave ablation therapies and embolic beads to cancer care solutions portfolio

Herlev University Hospital Treats First Patient In Denmark On Varian Halcyon System

Herlev University Hospital Treats First Patient In Denmark On Varian Halcyon System

PALO ALTO, Calif. and HERLEV, Denmark, June 10, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Herlev University Hospital near Copenhagen, Denmark is Scandinavia's first facility to utilize the Halcyon ™ system.

Varian-equipped New York Proton Therapy Center Opens With Ribbon Cutting Event

Varian-equipped New York Proton Therapy Center Opens With Ribbon Cutting Event

PALO ALTO, Calif., June 7, 2019 /PRNewswire/ -- Providing access to proton therapy treatment for cancer patients in the tri-state area, the New York Proton Center (NYPC) held a ribbon cutting event yesterday to commemorate the opening of the facility.

Varian To Host FlashForward Consortium Meeting At PTCOG58

Varian To Host FlashForward Consortium Meeting At PTCOG58

PALO ALTO, Calif., June 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be hosting its second FlashForward ™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58 th annual Particle Therapy Co-Operative Group meeting (PTCOG) in...

Varian Showcasing Latest Proton Therapy Systems And Technology At PTCOG Conference 58

Varian Showcasing Latest Proton Therapy Systems And Technology At PTCOG Conference 58

PALO ALTO, Calif., June 6, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced it will be showcasing its new ProBeam ® 360° proton therapy system*, June 12 th-15 th in Manchester, United Kingdom at the 58 th PTCOG Conference (Particle Therapy Co-Operative...

Varian To Showcase Software Solutions At ASCO Annual Meeting

Varian To Showcase Software Solutions At ASCO Annual Meeting

PALO ALTO, Calif., May 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing its Noona ® patient management system and its 360 Oncology™ care management platform, May 31-June 4 in Chicago, Illinois at the 2019 ASCO Annual...

Varian Eclipse User Takes Top Spot In 2019 TROG Pancreas Treatment Plan Study

Varian Eclipse User Takes Top Spot In 2019 TROG Pancreas Treatment Plan Study

PALO ALTO, Calif., May 28, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a physicist using Varian's Eclipse ™ treatment planning system achieved the top overall score in the TROG 2019 Stereotactic Body Radiation Therapy (SBRT) Pancreas Plan...

Varian Announces Definitive Agreement To Acquire Cancer Treatment Services International

Varian Announces Definitive Agreement To Acquire Cancer Treatment Services International

Advances Varian Toward Being a Broad-Based Cancer Solutions Company; Updates Annual Guidance

Varian Announces Incremental Gross Impact Of New Tariffs

Varian Announces Incremental Gross Impact Of New Tariffs

PALO ALTO, Calif., May 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced preliminary estimates of the incremental gross impact of new tariffs.

Cyclotron For Varian ProBeam Compact Proton Therapy System Installed At New Treatment Center In Singapore

Cyclotron For Varian ProBeam Compact Proton Therapy System Installed At New Treatment Center In Singapore

PALO ALTO, Calif. and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte.

Papua New Guinea Hospital Selects Varian Cancer Care Solution

Papua New Guinea Hospital Selects Varian Cancer Care Solution

PALO ALTO, Calif., May 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it was selected by Port Moresby General Hospital (PMGH) in Papua New Guinea to equip its cancer treatment center with the Halcyon ™ radiotherapy system, as well as the ARIA...

Varian Acquires CyberHeart

Varian Acquires CyberHeart

Company Adds Technology for Cardiac Radioablation to Its Radiation Medicine Portfolio

Varian Selected To Equip Two Proton Therapy Centers In Norway

Varian Selected To Equip Two Proton Therapy Centers In Norway

PALO ALTO, Calif., May 9, 2019 /PRNewswire/ -- Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton therapy centers in Norway with the ProBeam ® multi-room...

Varian And Shandong Cancer Hospital Form Proton Therapy Clinical Application And Research Partnership In China

Varian And Shandong Cancer Hospital Form Proton Therapy Clinical Application And Research Partnership In China

PALO ALTO, Calif. and JINAN, China, May 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton therapy clinical application and research.

Varian To Attend Upcoming Investor Events

Varian To Attend Upcoming Investor Events

PALO ALTO, Calif., May 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will be attending the UBS Global Healthcare Conference ( May 20-22) and the 2019 RBC Capital Markets Healthcare Conference ( May 21-22) in New York City.

South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments With Varian Bravos Afterloader System

South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments With Varian Bravos Afterloader System

PALO ALTO, Calif. and CAPE TOWN, South Africa, April 30, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced Groote Schuur Hospital in Cape Town, South Africa is the first hospital in Africa to deliver High Dose Rate (HDR) brachytherapy treatments with the...

Ofuna Chuo Hospital Delivers First Varian Halcyon System Treatments In Japan

Ofuna Chuo Hospital Delivers First Varian Halcyon System Treatments In Japan

PALO ALTO, Calif., April 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture, Japan is the first clinic in the country to begin treating cancer patients using the Halcyon ™ radiotherapy...

Varian Announces Global Clinical Consortium To Develop Evidence-based Protocols For Adaptive Radiotherapy

Varian Announces Global Clinical Consortium To Develop Evidence-based Protocols For Adaptive Radiotherapy

PALO ALTO, Calif., April 26, 2019 /PRNewswire/ -- Bringing together a global community of clinicians and scientists from leading cancer clinics to develop best practices for adaptive radiotherapy based on clinical evidence, Varian (NYSE: VAR) today...

Varian Reports Results For Second Quarter Of Fiscal Year 2019

Varian Reports Results For Second Quarter Of Fiscal Year 2019

Raises Revenue Guidance for Fiscal Year 2019

TheStreet Quant Rating: B (Buy)